Testicular Tissue Viability After Cryopreservation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2010 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01262495
First received: December 16, 2010
Last updated: NA
Last verified: December 2010
History: No changes posted
  Purpose

we will use testicular tissue from patient who underwent orchidectomy due to medical reasons and test the viability of the tissue after cryopreservation and de-freezing.


Condition Intervention
Fertility
Other: cryopreservation

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • viable tissue after cryopreservation [ Time Frame: 1/1/2011 - 30/12/2012 ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 5
Study Start Date: January 2011
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
orchidectomy
as specified in the summary
Other: cryopreservation
cryopreservation of testicular tissue

  Eligibility

Ages Eligible for Study:   15 Years to 75 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria: male patient undergo orchidectomy -

Exclusion Criteria: non viable testicular tissue

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01262495

Contacts
Contact: Doron Kabiri, MD 972-508946898 doronlilach@gmail.com

Locations
Israel
Hadassah Medical Organization Not yet recruiting
Jerusalem, Israel
Contact: hadassah    0508946898      
Principal Investigator: Doron Kabiri, MD         
Sponsors and Collaborators
Hadassah Medical Organization
  More Information

No publications provided

Responsible Party: hadassah
ClinicalTrials.gov Identifier: NCT01262495     History of Changes
Other Study ID Numbers: kabiri HMO-CTIL
Study First Received: December 16, 2010
Last Updated: December 16, 2010
Health Authority: Israel: Ethics Commission

ClinicalTrials.gov processed this record on August 19, 2014